Biogen (BIIB) Restructuring Costs (2010 - 2026)

Biogen (BIIB) has reported Restructuring Costs for 13 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Restructuring Costs fell 77.62% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $21.2 million (down 60.74% YoY), while the FY2025 annual figure was $48.6 million, up 60.93% from the prior year.
• Restructuring Costs came in at $7.9 million for Q1 2026 at Biogen, up from $6.6 million in the prior quarter.
• The five-year high for Restructuring Costs was $900.0 million in Q2 2022, with the low at -$700000.0 in Q2 2025.
• Average Restructuring Costs over 5 years is $68.5 million, with a median of $7.4 million recorded in 2025.
• Across the five-year window, Restructuring Costs soared 1311.43% in 2023 and tumbled 110.61% in 2025, its largest moves.
• Year by year, Restructuring Costs stood at $7.0 million in 2022, then jumped by 1311.43% to $98.8 million in 2023, then slumped by 94.64% to $5.3 million in 2024, then grew by 24.53% to $6.6 million in 2025, then increased by 19.7% to $7.9 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $7.9 million, $6.6 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.